Researchers have focused on gamma rhythm stimulation, particularly at 40 Hz, to enhance endogenous gamma oscillations and improve cognitive function and outcomes in Alzheimer’s disease (AD). However, some studies disputed these findings. This review aimed to systematically analyze recent randomized controlled trials on the effects of gamma stimulation on cognitive function in AD and to perform a meta-analysis to assess the efficacy, safety, and differences between brain and sensory stimulation.
Methods
A systematic search was conducted in PubMed, Web of Science, Ovid-Embase, and Ovid-MEDLINE from their inception to April 2024. A meta-analysis was performed to evaluate adverse events and cognitive function assessed using AD Assessment Scale-Cognitive Subscale (ADAS-cog), Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Face-Name Association Test (FNAT). Subgroup analyses were performed to explore the heterogeneity between the brain and sensory stimulation.
Results
Eight studies involving 291 participants were included. Meta-analysis demonstrated a large benefit in cognitive function: FNAT (standardized mean difference [SMD] = 3.76; 95% confidence interval [CI] = 2.52-4.99; I2 = 65%), MMSE (SMD = 3.09; 95% CI = 2.37-3.82; I2 = 0%), ADAS-cog (SMD = −4.16; 95% CI = −6.60 to −2.62; I2 = 0%), and MoCA (SMD = 2.17; 95% CI = −0.54 to 4.88; I2 = 0%). There were no significant differences in adverse events between the intervention and sham groups (P = .06), suggesting the safety of gamma stimulation.
Conclusion
This review highlights the safety and benefits of gamma stimulation for cognitive improvement in patients with AD, with sensory stimulation proving safe even in individuals with epilepsy.
ElmanJAMadisonCMBakerSL, et al. Effects of Beta-amyloid on resting state functional connectivity within and between networks reflect known patterns of regional vulnerability. Cereb Cortex. 2016;26:695-707.
4.
GrotheMJTeipelSJ.Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer’s disease correspond to dissociable functional brain networks. Hum Brain Mapp. 2016;37:35-53.
5.
CummingsJLTongGBallardC.Treatment combinations for Alzheimer’s disease: current and future pharmacotherapy options. J Alzheimers Dis. 2019;67(3):779-794.
6.
RosenJJessenF.Patient eligibility for amyloid-targeting immunotherapies in Alzheimer’s disease. J Prev Alzheimers Dis. 2025;12:100102.
7.
KimBHKimSNamYParkYHShinSMMoonM.Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives. Transl Neurodegener. 2025;14(1):6.
8.
WithingtonCGTurnerRS.Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer’s disease. Front Neurol. 2022;13: 862369.
9.
ThomGHatcherJHearnA, et al. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system. MAbs. 2018;10(2):304-314.
10.
Budd HaeberleinSAisenPSBarkhofF, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease. J Prev Alzheimers Dis. 2022;9(2):197-210.
11.
MengXFangSZhangS, et al. Multidomain lifestyle interventions for cognition and the risk of dementia: a systematic review and meta-analysis. Int J Nurs Stud. 2022;130:104236.
12.
LivingstonGHuntleyJSommerladA, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446. doi:10.1016/S0140-6736(20)30367-6
13.
MajdiADengZSadigh-EteghadSDe VlooPNuttinBMc LaughlinM.Deep brain stimulation for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Front Neurosci. 2023;17:1154180.
14.
BenussiACantoniVCotelliMS, et al. Exposure to gamma tACS in Alzheimer’s disease: a randomized, double-blind, sham-controlled, crossover, pilot study. Brain Stimul. 2021;14(3):531-540.
15.
NyhusECurranT.Functional role of gamma and theta oscillations in episodic memory. Neurosci Biobehav Rev. 2010;34:1023-1035.
16.
JadiMPBehrensMMSejnowskiTJ.Abnormal gamma oscillations in N-methyl-D-aspartate receptor hypofunction models of schizophrenia. Biol Psychiatry. 2016;79:716-726.
17.
IaccarinoHFSingerACMartorellAJRudenkoAGaoFGillinghamTZ. Gamma frequency entrainment attenuates amyloid load and modifes microglia. Nature. 2016;540:230-235.
18.
MartorellAJPaulsonALSukHJ, et al. Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell. 2019;177:256-271.e22.
19.
VenieroDVossenAGrossJThutG.Lasting EEG/MEG aftereffects of rhythmic transcranial brain stimulation: level of control over oscillatory network activity. Front Cell Neurosci. 2015;9:477.
20.
BobolaMSChenLEzeokekeCK, et al. Transcranial focused ultrasound, pulsed at 40 Hz, activates microglia acutely and reduces Aβ load chronically, as demonstrated in vivo. Brain Stimul. 2020;13:1014-1023.
21.
YangYLLaiTW.Chronic visual stimulation with LED light fickering at 24, 40, or 80 hz failed to reduce amyloid β load in the 5XFAD Alzheimer’s disease mouse model. eNeuro. 2023;10:ENEURO.0189-23.2023.
22.
HuYJiaYSunY, et al. Efficacy and safety of simultaneous rTMS-tDCS over bilateral angular gyrus on neuropsychiatric symptoms in patients with moderate Alzheimer’s disease: a prospective, randomized, sham-controlled pilot study. Brain Stimul. 2022;15(6):1530-1537.
23.
SoulaMMartín-ÁvilaAZhangY, et al. Forty-hertz light stimulation does not entrain native gamma oscillations in Alzheimer’s disease model mice. Nat Neurosci. 2023;26:570-578.
24.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1-11.
25.
BenussiACantoniVGrassiM, et al. Increasing brain gamma activity improves episodic memory and restores cholinergic dysfunction in Alzheimer’s disease. Ann Neurol. 2022;92(2):322-334.
26.
LiuCHanTXuZ, et al. Modulating Gamma oscillations promotes brain connectivity to improve cognitive impairment. Cereb Cortex. 2022;32(12):2644-2656.
27.
Mimenza-AlvaradoAJAguilar-NavarroSGMartinez-CarrilloFMRíos-PonceAEVillafuerteG.Use of fast gamma magnetic stimulation over the left prefrontal dorsolateral cortex for the treatment of MCI and Mild Alzheimer’s disease: a double-blind, randomized, sham-controlled, pilot study. Front Neurol. 2021;12:729872.
28.
ChanDSukHJJacksonBLMilmanNP, et al. Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: results of feasibility and pilot studies. PLoS One. 2022;17(12):e0278412.
29.
CimenserAHempelETraversT, et al. Sensory-evoked 40-Hz Gamma oscillation improves sleep and daily living activities in Alzheimer’s disease patients. Front Syst Neurosci. 2021;15:746859.
30.
AggerMPDanielsenERCarstensenMS, et al. Safety, feasibility, and potential clinical efficacy of 40 Hz invisible spectral flicker versus placebo in patients with mild-to-moderate Alzheimer’s disease: a randomized, placebo-controlled, double-blinded, pilot study. J Alzheimers Dis. 2023;92(2):653-665.
31.
SterneJACSavovićJPageMJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
32.
GuyattGOxmanADAklEA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394.
33.
ChenB.BenedettiA.Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes. Syst Rev. 2017;6(1):243. 10.1186/s13643-017-0630-4
34.
BiljanaMJelenaMBranislavJMiloradR.Bias in meta-analysis and funnel plot asymmetry. Stud Health Technol Inf. 1999;68:323-328.
35.
RentzDMAmariglioREBeckerJA, et al. Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia. 2011;49:2776-2783.
36.
LundstromBNPeterssonKMAnderssonJ, et al. Isolating the retrieval of imagined pictures during episodic memory: activation of the left precuneus and left prefrontal cortex. Neuroimage. 2003;20:1934-1943.
LiuKYSchneiderLSHowardR.The need to show minimum clinically important differences in Alzheimer’s disease trials. Lancet Psychiatry. 2021;8(11):1013-1016.
39.
ColeSRVoytekB.Brain oscillations and the importance of waveform shape. Trends Cogn Sci. 2017;21(2):137-149.
40.
ColginLLMoserEI.Gamma oscillations in the hippocampus. Physiology. 2010;25(5):319-329.
41.
SquireLRStarkCEClarkRE.The medial temporal lobe. Annu Rev Neurosci. 2004;27:279-306.
42.
WomelsdorfTFriesP.Neuronal coherence during selective attentional processing and sensory-motor integration. J Physiol Paris. 2006;100(4):182-193.
43.
HerrmannCSMunkMHEngelAK.Cognitive functions of gamma-band activity: memory match and utilization. Trends Cogn Sci. 2004;8(8):347-355.
44.
SingerW.Consciousness and the binding problem. Ann N Y Acad Sci. 2001;929:123-146. doi:10.1111/j.1749-6632.2001.tb05712.x
45.
JafariZKolbBEMohajeraniMH.Neural oscillations and brain stimulation in Alzheimer’s disease. Prog Neurobiol. 2020;194:101878.
46.
GovindpaniKCalvo-Flores GuzmánBVinnakotaCWaldvogelHJFaullRLKwakowskyA.Towards a better understanding of GABAergic remodeling in Alzheimer’s disease. Int J Mol Sci. 2017;18(8):1813.
47.
TraubRDBibbigALeBeauFEBuhlEHWhittingtonMA.Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro. Annu Rev Neurosci. 2004;27:247-278.
48.
RodriguezRKallenbachUSingerWMunkMH.Short- and long-term effects of cholinergic modulation on gamma oscillations and response synchronization in the visual cortex. J Neurosci. 2004;24(46):10369-10378.
49.
Camacho-CondeJAGonzalez-BermudezMDRCarretero-ReyMKhanZU.Brain stimulation: a therapeutic approach for the treatment of neurological disorders. CNS Neurosci Ther. 2022;28(1):5-18.
50.
BhattacharyaAMrudulaKSreepadaSS, et al. An overview of noninvasive brain stimulation: basic principles and clinical applications. Can J Neurol Sci. 2022;49(4):479-492.
51.
HuoLLiRWangP, et al. The default mode network supports episodic memory in cognitively unimpaired elderly individuals: different contributions to immediate recall and delayed recall. Front Aging Neurosci. 2018;10:1-10.
52.
AliMMSellersKKFröhlichF.Transcranial alternating current stimulation modulates large-scale cortical network activity by network resonance. J Neurosci. 2013;33:11262-11275.
53.
MunroCEDonovanNJGuercioBJ, et al. Neuropsychiatric symptoms and functional connectivity in mild cognitive impairment. J Alzheimers Dis. 2015;46(3):727-735.
54.
LismanJE.Three Ca2þ levels affect plasticity differently: the LTP zone, the LTD zone and no man’s land. J Physiol. 2001;532(Pt 2):285.
55.
AdaikkanCMiddletonSJMarcoA, et al. Gamma entrainment binds higher-order brain regions and offers neuroprotection. Neuron. 2019;102(5):929-943.e8.
56.
KuY.The mystery 40 Hz: unraveling the efficacy of rhythmic stimulation in Alzheimer’s disease. Neurosci Bull. 2024;40(6):831-834. doi:10.1007/s12264-023-01165-z
57.
ChenJMengXLiuZShangBChangCKuY.Decoding semantics from intermodulation responses in frequency-tagged stereotactic EEG. J Neurosci Methods. 2022;382:109727.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
